New PIP Court Ruling Sends Further Shockwaves Through EU Medtech Sector
Executive Summary
Notified bodies in the EU medtech sector have reason to feel nervous: recipients of the fraudulently manufactured PIP breast implants have had yet more court success in a case that is challenging the liability status of notified bodies at a critical time for EU regulation. But the final say is still awaited.
You may also be interested in...
European Court Weighs In On TÜV Rheinland PIP Case; Will It Vindicate The Notified Body?
TÜV Rheinland has had a nightmare time in national courts on liability questions relating to its involvement with the notorious PIP breast implants. Will new European Court of Justice legal findings vindicate it sufficiently to persuade national courts? And what will this mean for notified bodies more generally?
EU’s Legal Minefield Is A Notified Body Nightmare
There seems to be no way to tell which way the patient case against TÜV Rheinland tied to safety issues with the infamous PIP breast implants will go. The matter is creating significant uncertainty for notified bodies and the broader medtech legal community.
EU Experts Want One-Stop-Shop EU Governance That Mimics Best Of Other Jurisdictions
It may be blue sky thinking to surmise how a new EU medtech regulatory governance structure could evolve. But with change on the horizon, experts see exciting opportunities.